Syros

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Syros and other ETFs, options, and stocks.

About SYRS

Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. 

CEO
Nancy A. Simonian
CEONancy A. Simonian
Employees
124
Employees124
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2011
Founded2011
Employees
124
Employees124

SYRS Key Statistics

Market cap
129.90M
Market cap129.90M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
543.39K
Average volume543.39K
High today
$6.51
High today$6.51
Low today
$5.78
Low today$5.78
Open price
$6.08
Open price$6.08
Volume
173.87K
Volume173.87K
52 Week high
$48.00
52 Week high$48.00
52 Week low
$5.25
52 Week low$5.25

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

SYRS Earnings

-$5.40
-$3.60
-$1.80
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 4, Pre-Market
ActualExpected Nov 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.